Vanda Pharmaceuticals Inc.
Treatment of schizophrenia

Last updated:

Abstract:

Aspects of the invention relate generally to the treatment of schizophrenia and to monitoring for specific adverse reactions.

Status:
Grant
Type:

Utility

Filling date:

12 Dec 2016

Issue date:

27 Jul 2021